Atlas Trials

Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers

Clinical trial NCT00989872 · COMPLETED

Trial details

NCT number
NCT00989872
Sponsor
Enanta Pharmaceuticals, Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Skin and Soft Tissue InfectionsMethicillin-resistant Staphylococcus Aureus
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.